Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products ...

Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo, TransCon, SKYTROFA ®, and YORVIPATH ® are trademarks owned by the Ascendis Pharma group.

COPENHAGEN, Denmark, May 01, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the first quarter ended March 31, 2025, and provided a business update.

Silo Pharma’s SP-26 met all preclinical endpoints and aims to qualify for the FDA’s streamlined 505(b)(2) pathway. Today's manic market swings are creating the perfect setup for Matt’s next ...

Along with the proliferation of AI companies has come a proliferation of AI company logos. The fascinating thing, highlighted by several publications, is that many of these logos look near-identical.

Aurora Pharmaceutical, however, is taking a different approach. Aurora Pharmaceutical logo Under the leadership of CEO Dr. Mike Strobel - a career veterinarian who grew up on a cattle farm - the ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

From innovative treatments to unequal access to medicine, I cover health topics and keep an eye on Switzerland's Health Valley. I'm Swiss-Turkish, and have a background in communications ...

BERLIN, April 25, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of ...